|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,765.00 KRW | +5.76% |
|
-1.83% | -45.28% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-02 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENOME & COMPANY | Other Biotechnology & Medical Research | +5.76% | -1.83% | -45.28% | +23.24% | -80.79% | 105M |
-
|
-
|
-
|
- Stock Market
- Stocks
- A314130 Stock
- Charts Genome & Company
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
